Tags

Type your tag names separated by a space and hit enter

Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
J Laparoendosc Adv Surg Tech A. 2018 Sep; 28(9):1053-1060.JL

Abstract

BACKGROUND

Hilar cholangiocarcinoma (HCCA) is a rare tumor, usually associated with obstructive jaundice and unfavorable prognosis. Obstructive jaundice can affect the liver, kidney, heart, and the immune system of the patients. Currently, controversy exists in whether preoperative biliary drainage (PBD) is of any benefit to the patients, and the best way for PBD in patients with resectable HCCA of malignant biliary obstruction remains to be determined.

OBJECTIVES

To compare the clinical outcomes and effectiveness of endoscopic biliary drainage (EBD) treatment with those of percutaneous transhepatic biliary drainage (PTBD) treatment in patients with malignant biliary obstruction caused by resectable HCCA.

MATERIALS AND METHODS

The databases including MEDLINE, EMBASE, PubMed, CBM (China Biological Medicine Database), and CNKI were employed to identify the clinic trials on EBD versus PTBD for malignant biliary obstruction associated with resectable HCCA from January 2008 to October 2017. A systematic review and meta-analysis were carried out.

RESULTS

Six trials were identified and included in this study. Overall, the differences in technical success rate, R0 resection, incidence of total complication after resection, postoperative hospitalization time, resection time, and recurrence were not statistically significant between the EBD group and PTBD group (all P > .05). However, the incidence of total complications after EBD treatment is higher than that after PTBD treatment (P < .05).

CONCLUSION

For patients with obstructive jaundice associated with HCCA, current evidence indicate no superiority of PTBD over EBD regarding clinical feasibility and success rate, but data suggest a better clinical safety of PTBD compared with EBD in short-term postoperation. In long-term evaluation, the differences in clinical outcomes are not statistically significant between PTBD and EBD.

Authors+Show Affiliations

1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .2 Department of Ultrasonography, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin Medical University , Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .1 Department of Surgery, Third Central Hospital of Tianjin, Third Central Clinical College of Tianjin Medical University , Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China .

Pub Type(s)

Comparative Study
Journal Article
Meta-Analysis
Review
Systematic Review

Language

eng

PubMed ID

29641365

Citation

Liu, Jun-Guo, et al. "Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients With Resectable Hilar Cholangiocarcinoma: a Systematic Review and Meta-Analysis." Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A, vol. 28, no. 9, 2018, pp. 1053-1060.
Liu JG, Wu J, Wang J, et al. Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A. 2018;28(9):1053-1060.
Liu, J. G., Wu, J., Wang, J., Shu, G. M., Wang, Y. J., Lou, C., Zhang, J., & Du, Z. (2018). Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A, 28(9), 1053-1060. https://doi.org/10.1089/lap.2017.0744
Liu JG, et al. Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients With Resectable Hilar Cholangiocarcinoma: a Systematic Review and Meta-Analysis. J Laparoendosc Adv Surg Tech A. 2018;28(9):1053-1060. PubMed PMID: 29641365.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Endoscopic Biliary Drainage Versus Percutaneous Transhepatic Biliary Drainage in Patients with Resectable Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. AU - Liu,Jun-Guo, AU - Wu,Jing, AU - Wang,Jun, AU - Shu,Gui-Ming, AU - Wang,Yi-Jun, AU - Lou,Cheng, AU - Zhang,Jinjuan, AU - Du,Zhi, Y1 - 2018/03/12/ PY - 2018/4/12/pubmed PY - 2018/11/10/medline PY - 2018/4/12/entrez KW - biliary drainage KW - hilar cholangiocarcinoma KW - meta-analysis KW - obstructive jaundice SP - 1053 EP - 1060 JF - Journal of laparoendoscopic & advanced surgical techniques. Part A JO - J Laparoendosc Adv Surg Tech A VL - 28 IS - 9 N2 - BACKGROUND: Hilar cholangiocarcinoma (HCCA) is a rare tumor, usually associated with obstructive jaundice and unfavorable prognosis. Obstructive jaundice can affect the liver, kidney, heart, and the immune system of the patients. Currently, controversy exists in whether preoperative biliary drainage (PBD) is of any benefit to the patients, and the best way for PBD in patients with resectable HCCA of malignant biliary obstruction remains to be determined. OBJECTIVES: To compare the clinical outcomes and effectiveness of endoscopic biliary drainage (EBD) treatment with those of percutaneous transhepatic biliary drainage (PTBD) treatment in patients with malignant biliary obstruction caused by resectable HCCA. MATERIALS AND METHODS: The databases including MEDLINE, EMBASE, PubMed, CBM (China Biological Medicine Database), and CNKI were employed to identify the clinic trials on EBD versus PTBD for malignant biliary obstruction associated with resectable HCCA from January 2008 to October 2017. A systematic review and meta-analysis were carried out. RESULTS: Six trials were identified and included in this study. Overall, the differences in technical success rate, R0 resection, incidence of total complication after resection, postoperative hospitalization time, resection time, and recurrence were not statistically significant between the EBD group and PTBD group (all P > .05). However, the incidence of total complications after EBD treatment is higher than that after PTBD treatment (P < .05). CONCLUSION: For patients with obstructive jaundice associated with HCCA, current evidence indicate no superiority of PTBD over EBD regarding clinical feasibility and success rate, but data suggest a better clinical safety of PTBD compared with EBD in short-term postoperation. In long-term evaluation, the differences in clinical outcomes are not statistically significant between PTBD and EBD. SN - 1557-9034 UR - https://www.unboundmedicine.com/medline/citation/29641365/Endoscopic_Biliary_Drainage_Versus_Percutaneous_Transhepatic_Biliary_Drainage_in_Patients_with_Resectable_Hilar_Cholangiocarcinoma:_A_Systematic_Review_and_Meta_Analysis_ L2 - https://www.liebertpub.com/doi/full/10.1089/lap.2017.0744?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -